Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes

Cheah, C.Y. ; Chihara, D. ; Horowitz, S. ; Sevin, A. ; Oki, Y. ; Zhou, S. ; Fowler, N.H. ; Romaguera, J.E. ; Turturro, F. ; Hagemeister, F.B. ; Fayad, L.E. ; Wang, M. ; Neelapu, S.S. ; Nastoupil, L.J. ; Westin, J.R. ; Rodriguez, M.A. ; Samaniego, F. ; Anderlini, P. ; Nieto, Y. ; Fanale, M.A.

England: Elsevier Ltd

Texto completo disponível

First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG)

Ravaud, A. ; Oudard, S. ; De Fromont, M. ; Chevreau, C. ; Gravis, G. ; Zanetta, S. ; Theodore, C. ; Jimenez, M. ; Sevin, E. ; Laguerre, B. ; Rolland, F. ; Ouali, M. ; Culine, S. ; Escudier, B.

England: Elsevier Ltd

Texto completo disponível

Development of a geriatric vulnerability score in elderly patients with advanced ovarian cancer treated with first-line carboplatin: a GINECO prospective trial

Falandry, C. ; Weber, B. ; Savoye, A.-M. ; Tinquaut, F. ; Tredan, O. ; Sevin, E. ; Stefani, L. ; Savinelli, F. ; Atlassi, M. ; Salvat, J. ; Pujade-Lauraine, E. ; Freyer, G.

Oxford: Elsevier Ltd

Texto completo disponível

1363MO Cabazitaxel every 2 weeks versus every 3 weeks in older patients with metastatic castration-resistant prostate cancer (mCRPC): The CABASTY randomized phase III trial

Oudard, S. ; Beuzeboc, P. ; Voog, E. ; Barthelemy, P. ; Thiery-Vuillemin, A. ; Bennamoun, M. ; Hasbini, A. ; Aldabbagh, K. ; Saldana, C. ; Sevin, E. ; Amela, Y.E. ; Von Amsberg, G. ; Houede, N. ; Besson, D. ; Feyerabend, S. ; Boegemann, M. ; Pfister, D. ; Schostak, M. ; Huillard, O. ; Helissey, C.

Texto completo disponível

A phase II study of lenalidomide in platinum-sensitive recurrent ovarian carcinoma

Selle, F. ; Sevin, E. ; Ray-Coquard, I. ; Mari, V. ; Berton-Rigaud, D. ; Favier, L. ; Fabbro, M. ; Lesoin, A. ; Lortholary, A. ; Pujade-Lauraine, E.

Oxford: Elsevier Ltd

Texto completo disponível

First-line bevacizumab combined with reduced dose interferon-α2a is active in patients with metastatic renal cell carcinoma

Melichar, B. ; Koralewski, P. ; Ravaud, A. ; Pluzanska, A. ; Bracarda, S. ; Szczylik, C. ; Chevreau, C. ; Filipek, M. ; Delva, R. ; Sevin, E. ; Négrier, S. ; McKendrick, J. ; Santoro, A. ; Pisa, P. ; Escudier, B.

Elsevier Ltd

Texto completo disponível

Docetaxel (D) with androgen suppression (AS) for high-risk localized prostate cancer (HrPC) patients (pts) who relapsed PSA after radical prostatectomy (RP) and/or radiotherapy (RT): A randomized phase III trial

Oudard, S. ; Latorzeff, I. ; Caty, A. ; Miglianico, L. ; Sevin, E. ; Hardy Bessard, A-C. ; Delva, R. ; Rolland, F. ; Chevreau, C. ; Priou, F. ; Beuzeboc, P. ; Gravis, G. ; Linassier, C. ; Gomez, P. ; Voog, E. ; Chinet, P. ; Muracciole, X. ; Abraham Jaillon, C. ; Elaidi, R. ; Culine, S.

Elsevier Ltd

Texto completo disponível

Is There a Relationship Between Patient'S Satisfaction of the Diagnosis Announcement Device and Chemotherapy-Induced Nausea and Vomiting?

Gouerant, S. ; Dugue, A.E. ; Vanboeckstael, J. ; Allouache, D. ; Noal, S. ; Faveyrial, A. ; Delcambre, C. ; Galais, M. ; Lefebvre, A. ; Sevin, E. ; Polycarpe, F. ; Hrab, I. ; Brachet, P.E. ; Kaluzinski, L. ; Ngo, M.D. ; Vie, B. ; Lemenand, N. ; Grellard, J. ; Clarisse, B. ; Joly Lobbedez, F.

Texto completo disponível

1548PIS THERE A RELATIONSHIP BETWEEN PATIENT'S SATISFACTION OF THE DIAGNOSIS ANNOUNCEMENT DEVICE AND CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING?

Gouerant, S. ; Dugue, A.E. ; Vanboeckstael, J. ; Allouache, D. ; Noal, S. ; Faveyrial, A. ; Delcambre, C. ; Galais, M. ; Lefebvre, A. ; Sevin, E. ; Polycarpe, F. ; Hrab, I. ; Brachet, P.E. ; Kaluzinski, L. ; Ngo, M.D. ; Vie, B. ; Lemenand, N. ; Grellard, J. ; Clarisse, B. ; Joly Lobbedez, F.

Oxford University Press

Texto completo disponível

First Line Sunitinib in Type I and II Papillary Renal Cell Carcinoma (PRCC): Supap- A Phase II Study of the French Genito-Urinary Group (GETUG) and the Group of Early Phase Trials (GEP)

Ravaud, A. ; Oudard, S. ; De Fromont, M. ; Chevreau, C. ; Gravis, G. ; Zanetta, S. ; Theodore, C. ; Jimenez, M. ; Sevin, E. ; Escudier, B.

Texto completo disponível